Rossari Biotech Ltd

Rossari Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Rossari Biotech Ltd

₹ 842 3.19%
28 Jun - close price
rossari.com BSE: 543213 NSE: ROSSARI
About

Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. [1]

Their 3 main product categories are [2]:
- Home, personal care, and performance chemicals
- Textile specialty chemical
- Animal health and nutrition

The company has two R&D facilities, one at Silvassa manufacturing facility and a research lab at IIT Bombay. [3]

Key Points

Company Overview
Rossari Biotech is a Specialty-Chemicals manufacturer offering solutions for Home, Personal Care and Performance chemicals (HPPC), Textile specialty chemicals (TSC) and Animal Health and Nutrition (AHN). It offers a total of 4220+ products catering to an array of applications across FMCG, Home care, Industrial Cleaning, Personal Care, Textile, Performance Chemicals, Animal Health and Nutrition and Pet Care businesses. [1] [2]

Website BSE NSE
  • Market Cap ₹ 4,650 Cr.
  • Current Price ₹ 842
  • High / Low ₹ 904 / 657
  • Stock P/E 46.7
  • Book Value ₹ 174
  • Dividend Yield 0.06 %
  • ROCE 14.7 %
  • ROE 11.0 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 4.84 times its book value
  • Company has a low return on equity of 10.7% over last 3 years.
  • Dividend payout has been low at 3.37% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -4.37%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
201 204 339 269 262 234 241 237 264 258 332 299 314
166 174 300 243 234 207 213 205 228 223 290 258 272
Operating Profit 35 30 38 26 27 27 28 32 36 35 42 41 42
OPM % 18% 15% 11% 10% 10% 12% 12% 13% 14% 14% 13% 14% 13%
2 3 3 6 2 1 0 0 2 1 2 2 1
Interest 1 1 1 0 1 1 1 2 1 2 3 3 2
Depreciation 7 6 6 7 7 6 6 7 7 6 6 6 7
Profit before tax 29 27 33 24 22 21 21 24 30 29 36 35 35
Tax % 27% 26% 27% 25% 22% 26% 26% 26% 23% 26% 26% 27% 25%
21 20 24 18 17 15 15 17 23 22 26 26 26
EPS in Rs 4.12 3.63 4.43 3.32 3.06 2.79 2.80 3.17 4.20 3.91 4.78 4.62 4.74
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
122 178 233 292 516 600 690 1,073 975 1,203
108 166 209 247 438 495 569 950 853 1,042
Operating Profit 13 12 24 45 78 105 121 123 123 161
OPM % 11% 7% 10% 15% 15% 18% 18% 11% 13% 13%
0 0 1 1 1 4 10 13 4 7
Interest 3 3 2 1 3 4 3 3 5 10
Depreciation 5 4 4 5 12 17 22 26 26 24
Profit before tax 6 5 19 39 63 88 106 107 96 134
Tax % 11% 29% 17% 27% 28% 26% 25% 26% 25% 26%
5 3 16 29 46 66 79 79 71 100
EPS in Rs 11.59 7.77 35.43 65.73 104.07 12.91 15.23 14.43 12.94 18.04
Dividend Payout % 1% 0% 1% 0% 0% 4% 3% 3% 4% 3%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 20%
TTM: 23%
Compounded Profit Growth
10 Years: %
5 Years: 17%
3 Years: 8%
TTM: 40%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -11%
1 Year: -3%
Return on Equity
10 Years: %
5 Years: 14%
3 Years: 11%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 4 4 4 4 4 10 10 11 11 11
Reserves 27 41 56 85 116 273 394 774 848 949
38 22 24 22 9 67 0 0 65 68
24 37 37 49 119 118 140 141 202 253
Total Liabilities 93 104 122 160 248 468 544 926 1,126 1,281
43 36 37 44 74 94 171 177 155 167
CWIP 0 8 8 10 3 22 0 1 14 25
Investments 0 0 0 3 0 15 9 381 493 528
50 60 77 103 171 338 364 367 463 561
Total Assets 93 104 122 160 248 468 544 926 1,126 1,281

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 23 2 22 72 56 52 33 114 74
0 -5 -6 -16 -41 -187 -37 -318 -161 -70
0 -18 3 -6 -26 155 -29 297 61 -22
Net Cash Flow 0 1 -0 -1 5 23 -14 12 14 -18

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 70 59 74 75 61 57 73 62 91 92
Inventory Days 77 70 52 65 59 57 72 48 58 61
Days Payable 83 79 70 71 114 95 100 51 93 92
Cash Conversion Cycle 63 50 56 69 6 19 44 58 57 61
Working Capital Days 78 42 54 66 24 38 61 63 63 88
ROCE % 27% 42% 55% 38% 29% 18% 12%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
68.70% 68.56% 68.56% 68.56% 68.56% 68.46% 68.44% 68.44% 68.44% 68.35% 68.34% 68.32%
7.82% 8.46% 9.13% 9.03% 8.51% 8.84% 8.63% 7.46% 6.12% 5.74% 4.14% 4.02%
13.60% 12.87% 12.77% 12.29% 13.02% 14.15% 14.08% 15.09% 17.71% 17.68% 18.06% 17.74%
9.88% 10.10% 9.54% 10.12% 9.91% 8.55% 8.85% 9.01% 7.73% 8.23% 9.45% 9.90%
No. of Shareholders 49,32465,83176,49492,09998,56595,66497,08196,63495,37195,2001,00,42398,859

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls